Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48 EUR | -0.52% | -7.69% | -14.89% |
May. 16 | Pharmanutra S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Indices expected to rise ahead of macro data | AN |
Sales 2024 * | 113M 123M | Sales 2025 * | 129M 140M | Capitalization | 462M 502M |
---|---|---|---|---|---|
Net income 2024 * | 17M 18.47M | Net income 2025 * | 20M 21.73M | EV / Sales 2024 * | 4.03 x |
Net cash position 2024 * | 6.13M 6.67M | Net cash position 2025 * | 16.73M 18.18M | EV / Sales 2025 * | 3.44 x |
P/E ratio 2024 * |
26.8
x | P/E ratio 2025 * |
22.5
x | Employees | 105 |
Yield 2024 * |
1.84% | Yield 2025 * |
2.07% | Free-Float | 34.33% |
1 day | -0.52% | ||
1 week | -7.69% | ||
Current month | -10.11% | ||
1 month | -9.43% | ||
3 months | -22.71% | ||
6 months | -8.40% | ||
Current year | -14.89% |
Managers | Title | Age | Since |
---|---|---|---|
Andrea Lacorte
CEO | Chief Executive Officer | - | 02-12-31 |
Chief Tech/Sci/R&D Officer | - | - | |
Carlo Volpi
COO | Chief Operating Officer | - | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Giovanna Zanotti
BRD | Director/Board Member | 52 | 20-08-31 |
Andrea Lacorte
CEO | Chief Executive Officer | - | 02-12-31 |
Carlo Volpi
COO | Chief Operating Officer | - | 08-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 48 | -0.52% | 8,909 |
24-05-16 | 48.25 | +1.47% | 12,798 |
24-05-15 | 47.55 | +2.26% | 20,363 |
24-05-14 | 46.5 | -8.28% | 24,115 |
24-05-13 | 50.7 | -2.50% | 4,123 |
Real-time Borsa Italiana, May 17, 2024 at 11:44 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.89% | 502M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- PHN Stock